Oligodendrocyte progenitor cell proliferation (OPC proliferation)

Oligodendrocyte progenitor cell (OPC) proliferation is a fundamental cellular process in the central nervous system (CNS) characterized by the mitotic expansion of precursor cells destined to become myelin-producing oligodendrocytes. This process is primarily driven by signaling through the Platelet-derived growth factor receptor alpha (PDGFRA) and is crucial during both early development and adult life for the maintenance of white matter integrity. In pathological states like multiple sclerosis, the failure of OPCs to proliferate and subsequently differentiate leads to persistent demyelination and axonal loss. Therapeutic interventions aim to enhance OPC proliferation to ensure a sufficient supply of cells for remyelination, often by targeting G protein-coupled receptors or growth factor pathways. However, as this is a complex biological process rather than a single molecular target, drug discovery efforts focus on specific proteins that regulate this mitotic cycle.

Other names

OPC expansionOligodendrocyte precursor cell proliferationOligodendroblast proliferation

Drugs typically modulate this process by activating mitogenic pathways, such as the PDGF-PDGFRA axis, or by inhibiting negative regulatory signals like muscarinic M3 receptors and LINGO-1 to expand the progenitor pool prior to differentiation.